The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomas
- 28 April 2022
- journal article
- review article
- Published by Elsevier in La Presse Médicale
- Vol. 51 (1) , 104123
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise reviewChinese Clinical Oncology, 2019
- The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patientsBritish Journal of Dermatology, 2018
- The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary SyndromeAmerican Journal of Surgical Pathology, 2018
- Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJournal of Clinical Oncology, 2015
- Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeBone Marrow Transplantation, 2014
- Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2010
- Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 casesBlood, 2009
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- Incidence of Cutaneous T-Cell Lymphoma in the United States, 1973-2002Archives of Dermatology, 2007
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005